Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Tyra Biosciences, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 500 shares
@ $16.13, valued at
$8.1k
Sold 1,900 shares
@ $16.0337, valued at
$30.5k
Exercised 500 options to buy
@ $0.61, valued at
$305
Exercised 1,900 options to buy
@ $0.61, valued at
$1.2k
|
|
| 07/12/2023 |
4
| Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 1,202 shares
@ $16.0069, valued at
$19.2k
Sold 500 shares
@ $16.019, valued at
$8k
Exercised 201 shares
@ $0.61, valued at
$122.6
Sold 201 shares
@ $16.2304, valued at
$3.3k
Exercised 1,202 options to buy
@ $0.61, valued at
$733.2
Exercised 500 options to buy
@ $0.61, valued at
$305
Exercised 201 options to buy
@ $0.61, valued at
$122.6 |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4
| Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 10,862 shares
@ $16.4916, valued at
$179.1k
Sold 6,370 shares
@ $17.236, valued at
$109.8k
Sold 7,893 shares
@ $16.73, valued at
$132k
Sold 8,135 shares
@ $17.0897, valued at
$139k
Sold 13,524 shares
@ $16.906, valued at
$228.6k
Exercised 17,232 options to buy
@ $0.61, valued at
$10.5k
Exercised 16,028 options to buy
@ $0.61, valued at
$9.8k
Exercised 13,524 options to buy
@ $0.61, valued at
$8.2k
|
|
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 7,927 shares
@ $16.0048, valued at
$126.9k
Sold 12,773 shares
@ $16.1275, valued at
$206k
Exercised 7,927 options to buy
@ $2.25, valued at
$17.8k
Exercised 12,773 options to buy
@ $2.25, valued at
$28.7k
|
|
| 06/15/2023 |
4
| Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 5,628 shares
@ $16.0144, valued at
$90.1k
Sold 120 shares
@ $16.45, valued at
$2k
Sold 12,592 shares
@ $16.1453, valued at
$203.3k
Exercised 5,628 options to buy
@ $0.61, valued at
$3.4k
Exercised 120 options to buy
@ $0.61, valued at
$73.2
Exercised 12,592 options to buy
@ $0.61, valued at
$7.7k
|
|
| 06/02/2023 |
4
| KAPLAN GILLA (Director) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 06/02/2023 |
4
| Verjee Rehan (Director) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 06/02/2023 |
4
| CHEN ISAN (Director) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 06/02/2023 |
4
| Simson Jake (Director) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 06/02/2023 |
4
| Subramony Siddarth (10% Owner) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 06/02/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 06/02/2023 |
4
| MORE ROBERT J (Director) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 06/02/2023 |
4
| Kjellson Nina S (Director) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 14,500 options to buy
@ $14.47, valued at
$209.8k
|
|
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/17/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/17/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/17/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/05/2023 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 2,000 shares
@ $16.126, valued at
$32.3k
Exercised 2,000 options to buy
@ $2.25, valued at
$4.5k
|
|
| 04/03/2023 |
4
| Bensen Daniel (COO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 2,000 shares
@ $16.0075, valued at
$32k
Sold 400 shares
@ $16.0006, valued at
$6.4k
Sold 2,000 shares
@ $16.1569, valued at
$32.3k
Exercised 2,000 options to buy
@ $0.61, valued at
$1.2k
Exercised 400 options to buy
@ $0.61, valued at
$244
Exercised 2,000 options to buy
@ $0.61, valued at
$1.2k
|
|
| 03/31/2023 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 1,420 shares
@ $16.1835, valued at
$23k
Sold 2,407 shares
@ $16.0166, valued at
$38.6k
Sold 500 shares
@ $16.046, valued at
$8k
Exercised 1,420 options to buy
@ $2.25, valued at
$3.2k
Exercised 2,407 options to buy
@ $2.25, valued at
$5.4k
Exercised 500 options to buy
@ $2.25, valued at
$1.1k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|